Lung inflammation caused by adenosine-5'-triphosphate is mediatedvia Ca2+/PKCs-dependent COX-2/PGE2induction

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 8, 2013, Pages 1657-1668

  Leea, I Ta ^a   Lin, Chih Chung ^a   Lin, Wei Ning ^b   Wu, Wan Ling ^a   Hsiao, Li Der ^a   Yang, Chuen Mao ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Cyclooxygenase 2; Inflammation; Lung injury; Transcription factor

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE TRIPHOSPHATE; CALCIUM; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PROSTAGLANDIN E2; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; ROTTLERIN; SMALL INTERFERING RNA; SURAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PNEUMONIA;

MUS;

EID: 84884827679     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.05.006     Document Type: Article

References (37)

1. Britt RD Jr, Locy ML, Tipple TE, Nelin LD, Rogers LK. Lipopolysaccharide-inducedcyclooxygenase-2 expression in mouse transformed Clara cells. Cellular Physi-ology and Biochemistry 2012;29:213-22..
2. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacological Reviews 2006;58:58-86..
3. Carey MA, Germolec DR, Langenbach R, Zeldin DC. Cyclooxygenase enzymes inallergic inflammation and asthma. Prostaglandins Leukotrienes and Essential Fatty Acids 2003;69:157-62.. (Pubitemid 36976170)
4. Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, theMAPK-activated protein kinases. Microbiology and Molecular Biology Reviews 2011;75:50-83..
5. Dey A, Wong E, Kua N, Teo HL, Tergaonkar V, Lane D. Hexamethylene bisacetamide(HMBA) simultaneously targets AKT and MAPK pathway and represses NFκBactivity: implications for cancer therapy. Cell Cycle 2008;7:3759-67..
6. Eibl G, Bruemmer D, Okada Y, Duffy JP, Law RE, Reber HA, et al. PGE2is generatedby specific COX-2 activity and increases VEGF production in COX-2-expressinghuman pancreatic cancer cells. Biochemical and Biophysical Research Commu-nications 2003;306:887-97.. (Pubitemid 36776213)
7. Esther CR Jr, Alexis NE, Picher M. Regulation of airway nucleotides in chronic lungdiseases. Sub-Cellular Biochemistry 2011;55:75-93..
8. Gopalakrishna R, Jaken S. Protein kinase C signaling and oxidative stress. Free Radical Biology and Medicine 2000;28:1349-61.. (Pubitemid 30621479)
9. Heo JS, Han HJ. ATP stimulates mouse embryonic stem cell proliferation via pro-tein kinase C, phosphatidylinositol 3-kinase/Akt, and mitogen-activated proteinkinase signaling pathways. Stem Cells 2006;24:2637-48..
10. Isenovic ER, Fretaud M, Dobutovic B, Sudar E, Smiljanic K, Zaric B, et al. A novelhypothesis regarding the possible involvement of cytosolic phospholipase 2 ininsulin-stimulated proliferation of vascular smooth muscle cells. Cell Biology International 2009;33:386-92..
11. Kang YJ, Mbonye UR, DeLong CJ, Wada M, Smith WL. Regulation of intracellularcyclooxygenase levels by gene transcription and protein degradation. Progressin Lipid Research 2007;46:108-25.. (Pubitemid 46661865)
12. Katz S, Boland R, Santillan G. Modulation of ERK 1/2 and p38 MAPK signaling path-ways by ATP in osteoblasts: involvement of mechanical stress-activated calciuminflux, PKC and Src activation. International Journal of Biochemistry and Cell Biology 2006;38:2082-91.. (Pubitemid 44397616)
13. Klinker JF, Wenzel-Seifert K, Seifert R. G-protein-coupled receptors in HL-60 humanleukemia cells. General Pharmacology 1996;27:33-54..
14. Laubinger W, Tulapurkar ME, Schafer R, Reiser G. Distinct mono- and dinucleotide-specific P2Y receptors in A549 lung epithelial cells: different control ofarachidonic acid release and nitric oxide synthase expression. European Journalof Pharmacology 2006;543:1-7.. (Pubitemid 44092708)
15. 2+/PKC and MAPKs-induced EGFR transactivation. Journal of Cellular Bio-chemistry 2009;106:787-97..
16. Li J, Chen YJ, Quilley J. Effect of tempol on renal cyclooxygenase expression and activity in experimental diabetes in the rat. Journal of Pharmacology and Exper-imental Therapeutics 2005;314:818-24.. (Pubitemid 41043867)
17. Li H, Bradbury JA, Dackor RT, Edin ML, Graves JP, Degraff LM, et al. Cyclooxygenase-2regulates Th17 cell differentiation during allergic lung inflammation. American Journal of Respiratory and Critical Care Medicine 2011;184:37-49..
18. Lin CC, Lee CW, Chu TH, Cheng CY, Luo SF, Hsiao LD, et al. Transactivation of Src, PDGF receptor, and Akt is involved in IL-1 β-induced ICAM-1 expression in A549cells. Journal of Cellular Physiology 2007;211:771-80..
19. Lin CC, Lin WN, Wang WJ, Sun CC, Tung WH, Wang HH, et al. Functional cou-pling expression of COX-2 and cPLA2induced by ATP in rat vascular smoothmuscle cells: role of ERK1/2, p38 MAPK, and NF-κB. Cardiovascular Research 2009;82:522-31..
20. Lin CC, Lin WN, Cheng SE, Tung WH, Wang HH, Yang CM. Transactivation ofEGFR/PI3K/Akt involved in ATP-induced inflammatory protein expression and cell motility. Journal of Cellular Physiology 2012;227:1628-38..
21. Lindner SC, Kohl U, Maier TJ, Steinhilber D, Sorg BL. TLR2 ligands augment cPLA2 αactivity and lead to enhanced leukotriene release in human monocytes. Journalof Leukocyte Biology 2009;86:389-99..
22. Machida T, Ohta M, Onoguchi A, Iizuka K, Sakai M, Minami M, et al. 5-Hydroxytryptamine induces cyclooxygenase-2 in rat vascular smooth musclecells: Mechanisms involving Src, PKC and MAPK activation. European Journal ofPharmacology 2011;656:19-26 [corrected]..
23. Mortaz E, Folkerts G, Nijkamp FP, Henricks PA. ATP and the pathogenesis of COPD. European Journal of Pharmacology 2010;638:1-4..
24. Ozveren E, Korkmaz B, Buharalioglu CK, Tunctan B. Involvement ofcalcium/calmodulin-dependent protein kinase II to endotoxin-inducedvascular hyporeactivity in rat superior mesenteric artery. Pharmacological Research 2006;54:208-18.. (Pubitemid 44119201)
25. Park JY, Pillinger MH, Abramson SB. Prostaglandin E2synthesis and secretion: therole of PGE2synthases. Clinical Immunology 2006;119:229-40..
26. Polosa R, Blackburn MR. Adenosine receptors as targets for therapeutic interventionin asthma and chronic obstructive pulmonary disease. Trends in Pharmacolog-ical Sciences 2009;30:528-35..
27. Schafer R, Sedehizade F, Welte T, Reiser GATP-. UTP-activated P2Y recep-tors differently regulate proliferation of human lung epithelial tumor cells. American Journal of Physiology: Lung Cellular and Molecular Physiology 2003;285:L376-85.. (Pubitemid 36909454)
28. Schafer R, Hartig R, Sedehizade F, Welte T, Reiser G. Adenine nucleotides inhibitproliferation of the human lung adenocarcinoma cell line LXF-289 by activa-tion of nuclear factor κB1 and mitogen-activated protein kinase pathways. FEBSJournal 2006;273:3756-67.. (Pubitemid 44166656)
29. 2+in breast cancer (MCF-7) cells. Archives of Biochemistry and Biophysics 2007;466:15-23.. (Pubitemid 47405079)
30. Scodelaro BP, Boland R, Santillan G. ATP modulates transcription factors throughP2Y2 and P2Y4 receptors via PKC/MAPKs and PKC/Src pathways in MCF-7 cells. Archives of Biochemistry and Biophysics 2010;494:7-14..
31. Siomek A. NF-κB signaling pathway and free radical impact. Acta Biochimica Polonica 2012;59:323-31..
32. Trautmann A. Extracellular ATP in the immune system: more than just a dangersignal. Science Signaling 2009;2:e6..
33. Tucker DE, Ghosh M, Ghomashchi F, Loper R, Suram S, John BS, et al. Role ofphosphorylation and basic residues in the catalytic domain of cytosolic phos-pholipase A2α in regulating interfacial kinetics and binding and cellular function. Journal of Biological Chemistry 2009;284:9596-611..
34. Tzeng JI, Chen BC, Chang HM, Wang JJ, Sureshbabu M, Chien MH, et al. Involvementof phosphatidylcholine-phospholipase C and protein kinase C in peptidoglycan-induced nuclear factor-κB activation and cyclooxygenase-2 expression in RAW264.7 macrophages. Pharmacological Research 2010;61:162-6..
35. Williams M, Jarvis MF. Purinergic and pyrimidinergic receptors as potential drugtargets. Biochemical Pharmacology 2000;59:1173-85.. (Pubitemid 30157880)
36. 2+- and protein kinase C-dependent signaling pathwayfor nuclear factor-κB activation, inducible nitric-oxide synthase expression, and tumor necrosis factor-α production in lipopolysaccharide-stimulatedrat peritoneal macrophages. Journal of Biological Chemistry 2006;281:31337-47.. (Pubitemid 46041398)
37. Zhou HY, Shin EM, Guo LY, Youn UJ, Bae K, Kang SS, et al. Anti-inflammatory activityof 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expres-sion in RAW 264.7 macrophages via NF-κB, JNK and p38 MAPK inactivation. European Journal of Pharmacology 2008;586:340-9..